therapeutic antibodies in post genomics era | high-throughput antibody screening | lsa platform
Published 3 years ago • 2.2K plays • Length 1:22:45Download video MP4
Download video MP3
Similar videos
-
49:27
therapeutic antibody screening in post genomics era | ht-spr | carterra lsa platform | biotech
-
54:00
high quality therapeutic antibodies | high-throughput antibody screening | ht-spr | lsa platform
-
30:14
high res epitope binning | antibody screening | high-throughput antibody screening | lsa platform
-
22:43
ht-spr technology | high-throughput antibody screening | biology solutions | lsa platform
-
18:33
improve therapeutic antibody screening | leverage ht-spr to complement alphalisa | lsa platform
-
1:03:23
discovery of potent anti-pd-l1 antibodies | high-throughput antibody screening | lsa platform
-
47:07
advances in antibody discovery for bispecific therapeutics | biology solutions | antibody screening
-
56:57
high throughput antibody screening using synthetic antibody libraries with kinetic & binning assays
-
59:12
accelerating discovery of therapeutic antibodies using ht-spr | biology solutions | lsa platform
-
0:23
carterra 2022 symposium | high-throughput antibody screening | lsa platform
-
44:13
screen biotherapeutic targets using carterra's software suite | high-throughput antibody screening
-
1:00:03
carterra's high-throughput epitope analysis and the latest in antibody discovery
-
54:00
develop high quality therapeutic antibodies straight from selections in record time
-
45:02
speed up your antibody discovery | high-res epitope binning | biology solutions | lsa platform
-
1:02:41
high throughput characterization of ion channel activity blocking mabs with array spr | lsa platform
-
33:16
carterra cso speaks at sept 2018 seminar | monoclonal antibody (mab) | ht-spr | lsa platform
-
19:03
carterra scientist to scientist series | therapeutic antibody screening | biology solutions
-
48:19
precision high-throughput antibody screening against difficult targets
-
23:05
high throughput identification of genetically distinct, target-specific antibodies